These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38937754)

  • 1. Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients.
    Talia M; Cesario E; Cirillo F; Scordamaglia D; Di Dio M; Zicarelli A; Mondino AA; Occhiuzzi MA; De Francesco EM; Belfiore A; Miglietta AM; Di Dio M; Capalbo C; Maggiolini M; Lappano R
    J Transl Med; 2024 Jun; 22(1):597. PubMed ID: 38937754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
    Wang W; Li T; Xie Z; Zhao J; Zhang Y; Ruan Y; Han B
    J Transl Med; 2024 Jan; 22(1):57. PubMed ID: 38221616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients.
    Zhang R; Liu F
    J Transl Med; 2022 Oct; 20(1):453. PubMed ID: 36195908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
    Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated fibroblast-derived gene signature discriminates distinct prognoses by integrated single-cell and bulk RNA-seq analyses in breast cancer.
    Fang Z; Han YL; Gao ZJ; Yao F
    Aging (Albany NY); 2024 May; 16(9):8279-8305. PubMed ID: 38728370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
    Liu W; Wang M; Wang M; Liu M
    Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
    J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
    Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer.
    Li C; Yang L; Zhang Y; Hou Q; Wang S; Lu S; Tao Y; Hu W; Zhao L
    Front Immunol; 2023; 14():1307588. PubMed ID: 38235137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus clustering and development of a risk signature based on trajectory differential genes of cancer-associated fibroblast subpopulations in colorectal cancer.
    Yu K; Wang J; Wang Y; He J; Hu S; Kuai S
    J Cancer Res Clin Oncol; 2024 Aug; 150(8):388. PubMed ID: 39120743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer.
    Huang T; Lu C; Zhang Y; Lin BY; Zhang ZJ; Zhu D; Wang L; Lu Y
    Ann Med; 2023; 55(2):2250987. PubMed ID: 38375814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer.
    Lawrence MG; Pidsley R; Niranjan B; Papargiris M; Pereira BA; Richards M; Teng L; Norden S; Ryan A; Frydenberg M; Stirzaker C; Taylor RA; Risbridger GP; Clark SJ
    Clin Epigenetics; 2020 Mar; 12(1):48. PubMed ID: 32188493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.
    Yu L; Shen N; Shi Y; Shi X; Fu X; Li S; Zhu B; Yu W; Zhang Y
    Front Immunol; 2022; 13():1009789. PubMed ID: 36211448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer-associated fibroblast-related gene signature for predicting survival and therapy in gastric cancer.
    Zhou Z; Guo S; Lai S; Wang T; Du Y; Deng J; Zhang S; Gao G; Zhang J
    BMC Cancer; 2023 Jan; 23(1):108. PubMed ID: 36717783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.
    Lehmann BD; Ding Y; Viox DJ; Jiang M; Zheng Y; Liao W; Chen X; Xiang W; Yi Y
    BMC Cancer; 2015 Mar; 15():179. PubMed ID: 25886164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell analysis extracted CAFs-related genes to established online app to predict clinical outcome and radiotherapy prognosis of prostate cancer.
    Lai C; Wu Z; Li Z; Huang X; Hu Z; Yu H; Yuan Z; Shi J; Hu J; Mulati Y; Liu C; Xu K
    Clin Transl Oncol; 2024 May; 26(5):1240-1255. PubMed ID: 38070051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-Associated Fibroblasts Together with a Decline in CD8+ T Cells Predict a Worse Prognosis for Breast Cancer Patients.
    Kim HS; Noh YK; Min KW; Kim DH; Kwon MJ; Pyo JS; Lee JY
    Ann Surg Oncol; 2024 Mar; 31(3):2114-2126. PubMed ID: 38093168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel prognostic signature based on single-cell combined bulk RNA analysis in breast cancer.
    Xiao Y; Hu G; Xie N; Yin L; Pan Y; Liu C; Lou S; Zhu C
    J Gene Med; 2024 Feb; 26(2):e3673. PubMed ID: 38404059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.
    Lin W; Noel P; Borazanci EH; Lee J; Amini A; Han IW; Heo JS; Jameson GS; Fraser C; Steinbach M; Woo Y; Fong Y; Cridebring D; Von Hoff DD; Park JO; Han H
    Genome Med; 2020 Sep; 12(1):80. PubMed ID: 32988401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.